FIELD: chemistry; biochemistry.
SUBSTANCE: invention relates to biotechnology, specifically to obtaining hybrid proteins, and can be used in medicine during therapy of tuberculosis of the lungs, severe pneumonia, thermochemical inhalation burns, silicosis, respiratory distress syndrome and other diseases of the lungs. The hybrid protein gamma-interferon-surfactant-C which is expressed in Escherichia coli is obtained using a recombinant technique.
EFFECT: invention enables address delivery of gamma-interferon into lungs.
3 cl, 6 dwg, 1 tbl
Authors
Dates
2010-06-10—Published
2006-09-20—Filed